August 21st 2025, 3:00pm
The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.
August 21st 2025, 1:00pm
The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should be aware of.
August 20th 2025, 9:22pm
August 20th 2025, 9:00pm
CURE spoke with an expert about the needs of children in families living with cancer during back-to-school season.
August 20th 2025, 8:00pm
When a family member receives a diagnosis, it can present emotional challenges for children.
August 20th 2025, 7:00pm
Kimberly (Cary) Demirhan discusses the need for more diversity and inclusivity in clinical trials for patients with cancer.
August 20th 2025, 5:13pm
The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form.
August 20th 2025, 4:00pm
Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love by your side.
August 20th 2025, 3:00pm
Through cancer treatment, loss, as well as many life changes, I found healing in simple moments of community and laughter that lifted my spirit.
August 20th 2025, 1:00pm
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in an interview with CURE.
Top Lung Cancer Stories from October: Insights, and Patient Journeys
How AI Can Put Patients at the Center of Cancer Care
FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma
Sharing More Than 25 Years of Brain Tumor Survival